Terminal
Stocks
Spotlight
News

Stocks
Healthcare
OTC
ELTP

Market Cap: $321M

EI

Elite Pharmaceuticals, Inc.

ELTP

OTC (Other OTC)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

Cashu

Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Cashu Markets Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin43.21%

EBITDA Margin32.08%

EBIT Margin30.74%

Pre-tax Margin46.16%

Net Profit Margin40.19%

Earnings Yield17.69%

Valuation Multiples

Price / Book3.06

Price / Sales2.27

Price / Earnings5.95

PEG0.00

Forward PEG0.00

EV / Sales2.04

EV / EBITDA6.35

EV / Operating Cash Flow15.07

EV / Free Cash Flow16.38

Price / Free Cash Flow18.28

Price / Operating Cash Flow16.83

Cash Flow & Capital

Free Cash Flow / Share$0.02

Operating Cash Flow / Share$0.02

Free Cash Flow Yield5.47%

Capex / Revenue1.08%

Capex / Operating Cash Flow7.96%

Capex / Depreciation0.00

Stock Compensation / Revenue1.25%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio3.76

Quick Ratio2.97

Cash Ratio1.28

Debt / Assets0.04

Debt / Capital0.05

Debt / Equity0.05

Long-Term Debt / Capital0.03

Debt / Market Cap1.23%

Net Debt / EBITDA-0.74

Solvency Ratio1.68

Financial Leverage1.33

Efficiency & Working Capital

Asset Turnover1.01

Fixed Asset Turnover10.59

Inventory Turnover3.31

Receivables Turnover2.80

Payables Turnover14.32

Days Sales Outstanding130.56

Days Inventory Outstanding110.31

Days Payables Outstanding25.49

Operating Cycle240.87

Cash Conversion Cycle215.38

Working Capital Turnover1.58

Returns & Quality

Return on Equity65.59%

Return on Assets40.57%

Return on Invested Capital28.22%

ROCE32.77%

Return on Tangible Assets42.01%

Operating Return on Assets25.75%

Income Quality0.00

Tax Burden0.87

Interest Burden1.50

Balance Sheet & Intrinsic Metrics

Enterprise Value$287.04M

Invested Capital$102.16M

Working Capital$84.05M

Tangible Asset Value$100.04M

Net Current Asset Value$79.64M

Graham Number$0.34

Graham Net-Net$0.05

Book Value / Share$0.1

Tangible Book Value / Share$0.09

Cash / Share$0.04

Financial Health Scores

Piotroski Score5

Altman Z-Score7.62

Revenue$141.01M

EBIT$43.35M

Market Cap$323.16M

Working Capital$84.05M

Retained Earnings$-69.92M

Total Assets$139.67M

Total Liabilities$34.84M